Login / Signup

Diptoindonesin G antagonizes AR signaling and enhances the efficacy of antiandrogen therapy in prostate cancer.

Fengyi MaoYifan KongJinghui LiuXiongjian RaoChaohao LiKristine DonahueYanquan ZhangKatelyn JonesQiongsi ZhangWei XuXiaoqi Liu
Published in: The Prostate (2022)
Our results revealed that Dip G-mediated AR degradation would be a promising and valuable therapeutic strategy in the clinic.
Keyphrases
  • prostate cancer
  • radical prostatectomy
  • primary care
  • single cell
  • stem cells
  • mesenchymal stem cells
  • cell therapy